How much olive leaf extract is needed to lower blood pressure?

Studies typically use 500 to 1,000 mg per day of standardized extract. The 621-person trial used an oral dose taken once daily. If you are already on blood pressure medication, consult your doctor before adding any supplement to your regimen.

Can olive leaf extract replace blood pressure medication?

No. This trial evaluated olive leaf extract as a complementary approach, not a replacement for prescribed treatment. A 6.4 mmHg reduction is clinically meaningful, but decisions to change or stop medication must be made with your doctor.

Is olive leaf extract the same as olive oil?

No. Olive leaf extract contains oleuropein and hydroxytyrosol at much higher concentrations than olive oil. Clinical blood pressure research has been conducted almost exclusively with leaf extract, not oil, and the two cannot be directly compared for cardiovascular effects.

Olive Leaf Extract Lowers Systolic Blood Pressure by 6.4mmHg in 621-Person Trial

A 10 mmHg drop in systolic blood pressure is associated with roughly a 20% reduction in major cardiovascular events. That number sounds straightforward, but achieving it through lifestyle and nutrition alone is rarely simple. Salt restriction, aerobic exercise, and dietary shifts can each move the dial a few points, but sustained reductions of 5 mmHg or more through non-pharmacological means remain difficult to produce consistently. Olive leaf extract has been generating interest for exactly this reason, and a late-2025 clinical trial has now put the most precise numbers yet behind that interest.

Published in the Journal of Hypertension in November 2025, the study is the largest randomized controlled trial of olive leaf extract in hypertensive patients to date: 621 participants, 12 weeks, double-blind, placebo-controlled.

The Trial Design

The research team led by Feten Lamti, Imen Trabelsi, and colleagues at the University of Monastir in Tunisia enrolled 621 hypertensive patients and randomly assigned them to receive either olive leaf extract (OLE, n = 307) or placebo (n = 314) for 12 weeks. Blood pressure was evaluated using 24-hour ambulatory blood pressure monitoring (ABPM) rather than single clinic measurements.

This design choice matters. A clinic measurement captures one moment, influenced by stress, time of day, or white-coat anxiety. ABPM records blood pressure continuously through waking hours and sleep, capturing nocturnal dipping patterns, morning surge, and the full daily pressure burden on vessel walls. Research consistently shows ABPM predicts cardiovascular events more accurately than clinic readings alone.

The Results: Pressure Drop and Load Reduction

At week 12, the OLE group showed a 6.4 mmHg reduction in 24-hour systolic blood pressure from baseline (95% CI -10 to -2.1). The placebo group dropped just 1.5 mmHg (95% CI -3.9 to 0.51). The between-group difference was statistically significant (P < 0.01).

Beyond the headline number, the researchers tracked blood pressure load, defined as the proportion of time during a 24-hour period that blood pressure exceeded a defined threshold. This metric reflects cumulative vascular stress rather than a single peak reading:

Systolic BP load: decreased from 53.9% to 42.2% in the OLE group (P = 0.03)
Diastolic BP load: decreased from 30.7% to 21.2% (P = 0.03)
Diastolic BP variability: reduced by 13.3% (P = 0.04)

The drop in systolic load from 53.9% to 42.2% means that blood pressure exceeded the threshold for about 11 percentage points less of the day. Left ventricular hypertrophy, arterial stiffening, and kidney function decline are all more closely linked to sustained pressure load than to peak readings. These secondary findings give the result a clinical dimension that a simple mmHg number cannot fully convey.

Beyond Blood Pressure: Lipids and Inflammation

The trial also tracked cardiometabolic markers. Triglycerides, fasting glucose, body weight, and C-reactive protein (CRP) all showed significant reductions in the OLE group. CRP, a marker of systemic vascular inflammation, carries independent predictive weight for cardiovascular events in hypertensive patients. Its improvement alongside blood pressure metrics points to an anti-inflammatory dimension of OLE that goes beyond vasodilation.

For context on the lipid effects, a 2022 meta-analysis of 12 RCTs covering 819 participants found that OLE reduced triglycerides by an average of 14.32 mg/dL, LDL cholesterol by 4.60 mg/dL, and total cholesterol by 9.14 mg/dL specifically in hypertensive populations. The 2025 trial’s findings sit in line with that trajectory.

How Oleuropein Works

The primary bioactive compound in olive leaf is oleuropein. Its cardiovascular actions operate across several pathways. It stimulates nitric oxide (NO) production in vascular endothelial cells, promoting vasodilation. It inhibits angiotensin-converting enzyme (ACE), blocking a key signaling pathway that raises blood pressure. It also reduces LDL oxidation, slowing the formation of arterial plaques.

Hydroxytyrosol, a companion compound also concentrated in olive leaf extract, adds antioxidant and anti-inflammatory activity. Together, the two compounds appear to work synergistically. Standardized extracts that specify both oleuropein and hydroxytyrosol content tend to produce more consistent outcomes in clinical trials than extracts that standardize only one component.

What This Trial Adds and Where Its Limits Are

A double-blind, multicenter RCT with 621 participants is rare in this research area. Previous olive leaf extract trials were almost entirely small, single-center studies with 60 to 100 participants. The scale here shifts the weight of evidence meaningfully.

Several boundaries remain. Twelve weeks is too short to assess long-term safety or determine whether blood pressure improvements persist beyond the intervention period. The trial enrolled hypertensive patients, so whether OLE produces comparable effects in prehypertensive or normotensive individuals is not answered here. Drug interaction data for people already on antihypertensive medications is limited. The research team reported no significant adverse events, but longer-term safety monitoring data has yet to be published.

Choosing and Using Olive Leaf Extract

Oleuropein content varies widely across commercial products, from roughly 6% to 26%. Products that specify standardized oleuropein content on the label, typically around 16%, most closely match the extracts used in clinical research. A label that reads “standardized extract” without specifying the oleuropein percentage provides little guidance.

No particular time of day has been consistently identified as optimal for dosing. Taking OLE with food reduces the likelihood of gastrointestinal discomfort based on available reports.

If you are already taking polyphenol-rich supplements or consuming olive oil in significant quantities, calculating your combined daily polyphenol intake before adding OLE is the more precise starting point. More does not reliably mean better in this category, and stacking multiple polyphenol sources without tracking intake levels adds cost without guaranteed additive benefit. For blood pressure management specifically, a single standardized supplement at a consistent dose gives clearer feedback than layering several products with overlapping mechanisms.

Source: Journal of Hypertension